Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Aurinia Pharm Ord (AUPH)

Aurinia Pharm Ord (AUPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,188,915
  • Shares Outstanding, K 135,104
  • Annual Sales, $ 235,130 K
  • Annual Income, $ 5,750 K
  • EBIT $ 35 M
  • EBITDA $ 54 M
  • 60-Month Beta 1.16
  • Price/Sales 5.13
  • Price/Cash Flow 28.95
  • Price/Book 3.48

Options Overview Details

View History
  • Implied Volatility 38.96% ( -56.18%)
  • Historical Volatility 57.33%
  • IV Percentile 3%
  • IV Rank 6.45%
  • IV High 111.88% on 07/10/25
  • IV Low 33.93% on 06/04/25
  • Put/Call Vol Ratio 0.03
  • Today's Volume 409
  • Volume Avg (30-Day) 845
  • Put/Call OI Ratio 0.29
  • Today's Open Interest 47,800
  • Open Int (30-Day) 44,728

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/25
See More
  • Average Estimate 0.18
  • Number of Estimates 2
  • High Estimate 0.20
  • Low Estimate 0.16
  • Prior Year 0.02
  • Growth Rate Est. (year over year) +800.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
7.28 +22.99%
on 07/02/25
9.10 -1.54%
on 07/10/25
+0.78 (+9.54%)
since 06/13/25
3-Month
7.28 +22.99%
on 07/02/25
9.10 -1.54%
on 07/10/25
+1.23 (+15.91%)
since 04/14/25
52-Week
5.20 +72.47%
on 08/06/24
10.67 -16.03%
on 12/10/24
+3.35 (+59.71%)
since 07/12/24

Most Recent Stories

More News
Implied Volatility Surging for Aurinia Pharmaceuticals Stock Options

Investors in Aurinia Pharmaceuticals Inc. AUPH need to pay close attention to the stock based on moves in the options market lately. That is because the July 18, 2025 $2.00 Call had some of the highest...

AUPH : 8.95 (+1.70%)
Is the Options Market Predicting a Spike in Aurinia Pharmaceuticals (AUPH) Stock?

Investors in Aurinia Pharmaceuticals Inc. AUPH need to pay close attention to the stock based on moves in the options market lately. That is because the July 18, 2025 $2.00 Call had some of the highest...

AUPH : 8.95 (+1.70%)
Is the Options Market Predicting a Spike in Aurinia Pharmaceuticals (AUPH) Stock?

Investors in Aurinia Pharmaceuticals Inc. AUPH need to pay close attention to the stock based on moves in the options market lately. That is because the July 18, 2025 $2.00 Call had some of the highest...

AUPH : 8.95 (+1.70%)
Aurinia: Q1 Earnings Snapshot

Aurinia: Q1 Earnings Snapshot

AUPH : 8.95 (+1.70%)
Zacks Industry Outlook Highlights Aurinia Pharmaceuticals, Heron Therapeutics, Esperion Therapeutics, Pyxis Oncology and Plus Therapeutics

For Immediate ReleaseChicago, IL – April 24, 2025 – Today, Zacks Equity Research discusses Aurinia Pharmaceuticals AUPH, Heron Therapeutics HRTX, Esperion Therapeutics ESPR, Pyxis Oncology PYXS and...

ESPR : 1.2050 (+1.26%)
PSTV : 0.3386 (-5.87%)
PYXS : 1.1600 (unch)
AUPH : 8.95 (+1.70%)
HRTX : 2.11 (-3.21%)
Mainz Biomed Vs. Aurinia Pharma: Retail Traders Weigh In On The Better Biotech Bet

Over the past three months, Mainz has seen a staggering 2,500% increase in message volume on Stocktwits, while Aurinia’s engagement has grown just 23%.

AUPH : 8.95 (+1.70%)
MYNZ : 1.8300 (-4.69%)
Are Options Traders Betting on a Big Move in Aurinia Pharmaceuticals (AUPH) Stock?

Investors in Aurinia Pharmaceuticals Inc. AUPH need to pay close attention to the stock based on moves in the options market lately. That is because the April 17, 2025 $4 Call had some of the highest implied...

AUPH : 8.95 (+1.70%)
Aurinia: Q4 Earnings Snapshot

Aurinia: Q4 Earnings Snapshot

AUPH : 8.95 (+1.70%)
Implied Volatility Surging for Aurinia Pharmaceuticals (AUPH) Stock Options

Investors in Aurinia Pharmaceuticals Inc. AUPH need to pay close attention to the stock based on moves in the options market lately. That is because the Jan 17, 2025 $20 Put had some of the highest implied...

AUPH : 8.95 (+1.70%)
Aurinia Pharma Surges Pre-Market After Director Kevin Tang Discloses $10M Stock Buy: Retail Confidence Spikes

Aurinia has been under the spotlight recently due to significant restructuring efforts.

AUPH : 8.95 (+1.70%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Buy with a Strongest short term outlook on maintaining the current direction.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Business Summary

Aurinia Pharmaceuticals Inc. is a late stage biopharmaceutical company. It focuses on the development of therapeutic immunomodulating drug candidate. The company's lead drug includes Voclosporin for the treatment of lupus nephritis. Aurinia Pharmaceuticals Inc. is headquartered in Victoria, Canada.

See More

Key Turning Points

3rd Resistance Point 9.25
2nd Resistance Point 9.16
1st Resistance Point 8.98
Last Price 8.95
1st Support Level 8.70
2nd Support Level 8.61
3rd Support Level 8.43

See More

52-Week High 10.67
Last Price 8.95
Fibonacci 61.8% 8.58
Fibonacci 50% 7.93
Fibonacci 38.2% 7.29
52-Week Low 5.20

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar